Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Inflammatory Breast Neoplasms 1

Interventions

Cyclophosphamide 9Epirubicin 6Docetaxel 6Fluorouracil 4Bevacizumab 4Trastuzumab 3Tamoxifen 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Neoadjuvant Therapy 3Thiotepa 2Paclitaxel 2Filgrastim 2Carboplatin 2pembrolizumab 1aldesleukin 1Vinorelbine 1Therapeutics 1Methotrexate 1Mesna 1Hypnosis 1High-Energy Shock Waves 1Goserelin 1Early Intervention, Educational 1Doxorubicin 1Cisplatin 1Chemotherapy, Adjuvant 1Capecitabine 1CMF regimen 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Inflammatory Breast Neoplasms × CMF regimen × Clear all
NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡